Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction.
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80.
Permanent control of HIV-1 pathogenesis in exceptional elite controllers: a model of spontaneous cure.
HIV-1 DNA decay dynamics in early treated individuals: practical considerations for clinical trial design.
Small steps forward for HIV vaccine development.
A Summary of the Fourth Annual Virology Education HIV Microbiome Workshop.
Visfatin as a therapeutic target for rheumatoid arthritis.
Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis.
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMix.
Comparison of Safety and Vector-Specific Immune Responses in Healthy and HIV-Infected Populations Vaccinated with MVA-B.